Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May 7;18(3):888-899.
doi: 10.20892/j.issn.2095-3941.2020.0464.

Epstein-Barr virus DNA loads in the peripheral blood cells predict the survival of locoregionally-advanced nasopharyngeal carcinoma patients

Yongqiao He #  1   2 , Dawei Yang #  2   3 , Ting Zhou  2 , Wenqiong Xue  2 , Jiangbo Zhang  2 , Fangfang Li  2   4 , Fang Wang  1   2 , Tongmin Wang  2 , Ziyi Wu  2 , Ying Liao  2 , Meiqi Zheng  2   3 , Changmi Deng  2 , Danhua Li  2 , Yijing Jia  2   3 , Leilei Yuan  2   3 , Wenli Zhang  2 , Weihua Jia  1   2   3
Affiliations

Epstein-Barr virus DNA loads in the peripheral blood cells predict the survival of locoregionally-advanced nasopharyngeal carcinoma patients

Yongqiao He et al. Cancer Biol Med. .

Abstract

Objective: Circulating cell-free Epstein-Barr virus (EBV) DNA has been shown to be a valuable biomarker for population screening and prognostic surveillance for nasopharyngeal carcinoma (NPC). Despite important insights into the biology of persistence, few studies have addressed the clinical significance of cell-based EBV-DNA loads in peripheral blood cells (PBCs).

Methods: A prospective observational cohort study was conducted involving 1,063 newly diagnosed, locoregionally-advanced NPC patients at Sun Yat-sen University Cancer Center from 2005 to 2007. Cox regression analysis was conducted to identify the association of PBC EBV DNA loads to overall survival (OS) and other prognostic outcomes. Prognostic nomograms were developed based on PBC EBV DNA loads to predict survival outcomes for NPC patients.

Results: After a median follow-up of 108 months, patients with higher PBC EBV-DNA loads had significantly worse OS [hazard ratio (HR) of medium, medium-high, and high vs. low were 1.50, 1.52, and 1.85 respectively; Ptrend < 0.001]. Similar results were found for progression-free survival and distant metastasis-free survival. The concordance index of the prognostic nomogram for predicting OS in the training set and validation set were 0.70 and 0.66, respectively. Our data showed that the PBC EBV DNA load was an independent and robust survival biomarker, which remained significant even after adjusting for plasma EBV DNA loads in a subset of 205 patients of the cohort (HR: 1.88; P = 0.025). Importantly, a combination of PBC EBV DNA load and plasma EBV DNA load improved the predicted OS.

Conclusions: The EBV-DNA load in PBCs may be an independent prognosis marker for NPC patients.

Keywords: Epstein-Barr virus DNA; Nasopharyngeal carcinoma; nomogram; peripheral blood cells; prognosis.

PubMed Disclaimer

Conflict of interest statement

No potential conflicts of interest are disclosed.

Figures

Figure 1
Figure 1
Kaplan-Meier survival curves of Epstein-Barr virus DNA in peripheral blood cells for (A) overall survival, (B) progression-free survival, (C) distant metastasis-free survival, and (D) recurrence-free survival in all patients.
Figure 2
Figure 2
Nomogram (A), including age, gender, education level, T stage, N stage, concurrent chemotherapy, body mass index, smoking status, serum lactate dehydrogenase levels, and neutrophil to lymphocyte ratio for 3-, 5-, and 10-year overall survival (OS) in patients with nasopharyngeal carcinoma. The calibration curve (B) of the nomogram for predicting OS. The Kaplan-Meier curves (C) of different risk groups in the training and validation sets according to the score system for the OS.
Figure 3
Figure 3
A scatter plot (A) indicating the correlation between plasma Epstein-Barr virus (EBV) DNA and peripheral blood cell (PBC) EBV DNA. Grep points are the jittered points. Kaplan-Meier survival curves of overall survival. (B) plasma EBV DNA alone, (C) PBC EBV DNA alone, (D) The combination of plasma EBV DNA and PBC EBV DNA.
See this image and copyright information in PMC

References

    1. Plummer M, de Martel C, Vignat J, Ferlay J, Bray F, Franceschi S. Global burden of cancers attributable to infections in 2012: a synthetic analysis. Lancet Glob Health. 2016;4:e609–16. - PubMed
    1. Klein G. Nasopharyngeal carcinoma (NPC) is an enigmatic tumor. Semin Cancer Biol. 2002;12:415–8. - PubMed
    1. Wei KR, Zheng RS, Zhang SW, Liang ZH, Li ZM, Chen WQ. Nasopharyngeal carcinoma incidence and mortality in China, 2013. Chin J Cancer. 2017;36:90. - PMC - PubMed
    1. Tao Q, Chan AT. Nasopharyngeal carcinoma: molecular pathogenesis and therapeutic developments. Expert Rev Mol Med. 2007;9:1–24. - PubMed
    1. Lee AW, Fee WE, Jr, Ng WT, Chan LK. Nasopharyngeal carcinoma: salvage of local recurrence. Oral Oncol. 2012;48:768–74. - PubMed

LinkOut - more resources